Glucagon-like peptide (GLP)-1 analogues as an add-on to insulin for adults with type 1 diabetes mellitus

To assess the effects of adding GLP-1 analogues to insulin for treatment of adults with type 1 diabetes mellitus.

This is a protocol.

Health topics:

Insurance medicine > Sick Leave > Endocrine & metabolic

Published:

1 November 2018

Authors:

Yamada T, Mori R, Hosoe J, Shojima N, Kamata R, Ishinohachi K, Yamauchi T, Tanikawa Y, Kadowaki T

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Yamada T, Mori R, Hosoe J, Shojima N, Kamata R, Ishinohachi K, Yamauchi T, Tanikawa Y, Kadowaki T. Glucagon-like peptide (GLP)-1 analogues as an add-on to insulin for adults with type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, Issue 11. Art. No.: CD013164. DOI: 10.1002/14651858.CD013164